TIVC
Tivic Health Systems, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$0.26
−10.46%Price chart
Jul 24Jul 29Aug 3Aug 6Aug 11Aug 14Aug 19Aug 24
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−1.0x
Market Cap
$340364.49
MomentumView details →
1D Return
−10.46%
YTD Return
−88.55%
RSI (14)
33.8
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−1.0x
Market Cap
$340364.49
RSI (14)
33.8
MomentumView details →
1D Return
−10.46%
YTD Return
−88.55%
SummaryUpdated Jun 1, 2026
Tivic Health Systems, Inc. (NASDAQ:TIVC) is a bioelectronic medical device company founded in 2016 and headquartered in Hayward, California. The company went public in November 2021 and has undergone a significant strategic transformation from a single-product consumer device company to a diversified immunotherapeutics company. Originally focused on its ClearUP sinus relief device, Tivic has expanded its portfolio to include late-stage pharmaceutical assets and advanced bioelectronic therapies, positioning itself at the intersection of biologic and bioelectronic medicine for treating inflammatory and immune system disorders.
Similar companies
Latest newsMore news →
Valion Bio, Inc. signed a letter agreement with 3i, LP to issue Series B and Series C preferred shares and warrants to purchase common stock for an aggregate purchase price of $7,737,000.3d agoValion Bio, Inc. appointed Lisa Wolf as Chief Operating Officer and Chief Financial Officer, effective August 16, 2026.19d agoDean Zikria was elected as a Class II director of Valion Bio, Inc., effective May 28, 2026.94d ago